Trade DNTH anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Dianthus Therapeutics, Inc. (DNTH) is trading at US$108.52, down 2.71% today as of Aug 28, 11:37 EDT. The company has a market capitalisation of US$6.21B. Over the past 52 weeks, DNTH has traded between US$22.81 and US$117.88. On Syfe you can trade DNTH with $0 commission and add it to your watchlist.
| Previous close | US$111.54 |
|---|---|
| Market cap | US$6.21B |
| 52-week range | US$22.81 – US$117.88 |
| Volume | 596.48K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Dianthus Therapeutics, Inc.
Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company. It designs and delivers novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company was founded on June 17, 2015 and is headquartered in New York, NY.
Year: 2023
Dianthus Therapeutics Begins Phase 3 Trial of Treatment for Rare Autoimmune Disorder
Jun 29, 12:05 PM · MT Newswires
Dianthus Therapeutics, Inc. (DNTH) stock is trading at US$108.52, -2.71% from the previous close of US$111.54.
The market cap for Dianthus Therapeutics, Inc. (DNTH) stock is approximately US$6.21B.
The 52-week high for Dianthus Therapeutics, Inc. (DNTH) stock is US$117.88.
The 52-week low for Dianthus Therapeutics, Inc. (DNTH) stock is US$22.81.
Dianthus Therapeutics, Inc. (DNTH) does not currently pay a dividend.
Stay on top of DNTH
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
